Sartorius sends U.S. peers higher after Q1 2025 results
Source: SeekingAlpha
2025-04-16 09:29:45 ET
More on Danaher, Repligen, etc.
- Thermo Fisher Scientific And Its Real Value
- Danaher: Operational Excellence Meets Cyclical Pause - A Hold Amid Recovery Prospects
- Danaher Corporation: A Mixed Bag Of Strength And Stagnation
- Sartorius Aktiengesellschaft Non-GAAP EPS of €1.23, revenue of €883M; initiates FY25 outlook
- Europe indexes start the week with strong gains, led by tariff relief for tech
Read the full article on Seeking Alpha
For further details see:
Sartorius sends U.S. peers higher after Q1 2025 results
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
11.5% G/L:
$277.42 Last:
471,754 Volume:
$274.72 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
